))
Dr. Jen Rogers on the Use of CB-CAPs to Assess Disease Activity in SLE
Manage episode 352279466 series 3428257
内容由Exagen Podcast提供。所有播客内容（包括剧集、图形和播客描述）均由 Exagen Podcast 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
What is the Type 1 vs Type 2 Lupus Model? How does it shape the care and management of lupus patients? And what impact does it have on the future of drug development to address Type 2 symptoms?
Join Exagen and Dr. Jen Rogers, Director of the Duke Lupus Clinic as she breaks down the abstract, The Use of Cell-bound Complement Activation Product to Assess Disease Activity in SLE, how the study came to be, and its clinical importance to both providers and patients.
3集单集
分享
